
Risk of heart disease raised in patients with diabetes, says research by Rajiv Gandhi Centre for Biotechnology
The Hindu
Cyclophilin A, a type of protein, pinpointed as potential drug target
Researchers at the Rajiv Gandhi Centre for Biotechnology (RGCB) here have published findings that could help reduce the risk of heart disease in patients with diabetes.
The researchers have pinpointed Cyclophilin A, a protein that plays a role in several diseases in humans, as a potential drug target for reducing heart disease risk in such patients.
More Related News